Other Members

Read More.

His key research interests include preventive oncology in relation to cervical cancer.
Read More.

Her current research focuses on strategies to eliminate cervical cancer in low resource setting and impact of HPV vaccination in cervical cancer screening.

Read More.

His key research interest includes clinical trials in cervical cancer.
Read More.

His area of expertise resides mainly in Drug development, Translational Glycoimmunology, Proteomics and Glycomics in gynaecological cancer.
Read More.

Santu Kumar Saha: He is currently pursuing an Newton Fellowship under the supervision of Professor Nicola Curtin at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.His work includes hypoxia and radiosensitization using PARP inhibitors in cervical cancers.
Read More.

Her previous research work includes basic and translational studies in cervical cancer. Currently she is working on DDR in ovarian cancer at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.
Read More.

Her key research interest includes neuro-inflammation, immunology and cancer biology in relation to cervical and ovarian cancer.

Read More.

Her previous and current research interest includes cervical cancer preventions.
Read More.

He is a member of the World Health Organization Steering Committee for Oncology, member of ESMO Global Policy Committee, and coordinator for ESMO Global Opioid Policy Initiative.
Read More.

His key research interest includes cellular metabolism in ovarian cancer and therapeutic targets.

His key research area focuses on quality of life assessment in cancers.

His research primarily focuses on HPV associated cancer, deciphering its molecular mechanism of carcinogenesis for identification of epigenetic marks in early prediction of cervical preneoplastic and cancerous stages; deciphering the role of non-invasive biomarkers in High-Risk HPV associated Head and Neck Squamous Cell Carcinoma development and also evaluation of prevalence and oncogenic potential of novel HPV types. Read More.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancer.
Read More.

His key research area focuses on basic and translational aspects of chemoresistance in ovarian and cervical cancer in correlation with micro RNA.
Read More.

Dr. Damayanti Das Ghosh is presently studying whether any correlation is present between stemness and presence of GOF mutant p53 and, whether such correlation is associated with chemoresistance in high grade serous ovarian cancer. Her second work is related to developing organoids from ovarian and cervical tumors. In cancer research, organoids can be used for both studying basic biology of the disease and for testing drug-sensitivity. She is also working on TCGA Data-mining on ovarian and endometrial cancer. Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr Biswarup Basu is Senior Scientific Officer at CNCI and his area of interest is deciphering neuronal regulations on cancer progression. He is engaged in identifying key proteins in autophagy and neuro-endocrine pathways that may serve as potential biomarkers and targets against cancer metastasis in breast and ovarian cancers. Dr Basu is also working on natural compounds with anticancer properties in ovarian tumor models. His other research interest involves the development of biomaterials to accelerate wound healing and facilitate sustained delivery of oral drugs. Read More.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Her research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

The major objective of his lab is to understand the mechanism (s) dampening the objective repose of the anti-tumor T cells in cancer,primarily focusing on:

• To elucidate the role of cellular metabolisms in remodeling of the anti-tumor response of T cells.
• Determine the crosstalk between metabolic adaptation and stress response pathways in modulating the therapeutic efficacy of anti-tumor T cell.
• Determine the role of cellular metabolism in shaping up the epigenetic landscape of anti-tumor T cells.

Read More.